We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Frameshift Mutation Linked to Early-Onset Parkinson's

By Biotechdaily staff writers
Posted on 16 Jul 2003
A recent study reports the identification of a genetic sequence alteration on the DJ-1 gene that may be related to early-onset Parkinson's disease.

Investigators at the National Institute of Aging (Bethesda, MD, USA; www.nih.gov) analyzed the DNA sequence of the DJ-1 gene in 107 patients with Parkinson's disease, 69 of whom had no family history of the disease. More...
In one of these cases of typical Parkinson's, they discovered two separate mutations in the DJ-1 gene. This patient, who was diagnosed with probable Parkinson's disease at age 24 with asymmetric onset and an excellent response to levodopa therapy, had a frameshift mutation in the first coding exon and an exon 7 splice mutation, both predicted to result in a loss of functional protein.

"Showing that a mutation in DJ-1 can cause disease in the absence of a family history is an important point,” explained senior author Dr. Andrew Singleton, a researcher at the Laboratory of Neurogenetics of the National Institute of Aging. "A concept that many scientists as well as laypeople forget is that just because there is no family history does not mean the disease is not genetic.”




Related Links:
National Institute of Aging

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
New
Gold Member
Platelet Function Analyzer
AGGRENG-40
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.